Triple
T15313580
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CRISPR-Cas9 gene-editing technology |
E366097
|
entity |
| Predicate | hasVariant |
P455
|
FINISHED |
| Object |
SaCas9
SaCas9 is a compact Cas9 nuclease derived from Staphylococcus aureus that enables CRISPR-based genome editing, particularly useful where smaller delivery vectors such as AAV are required.
|
E1150943
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SaCas9 | Statement: [CRISPR-Cas9 gene-editing technology, hasVariant, SaCas9]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SaCas9 Context triple: [CRISPR-Cas9 gene-editing technology, hasVariant, SaCas9]
-
A.
Cpf1 (Cas12a)
Cpf1 (Cas12a) is a CRISPR-associated endonuclease used for genome editing that recognizes different DNA target sequences and creates staggered cuts, offering distinct advantages and applications compared to Cas9.
-
B.
CASP13
CASP13 is the 13th Critical Assessment of protein Structure Prediction experiment, an international community-wide competition that benchmarks computational methods for predicting 3D protein structures.
-
C.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
-
D.
CASP14
CASP14 is the fourteenth edition of the Critical Assessment of protein Structure Prediction experiment, a community-wide benchmark for evaluating computational methods in protein structure modeling.
-
E.
CESAER
CESAER is a European association of leading universities of science and technology that collaborates to advance engineering education, research, and innovation.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: SaCas9 Triple: [CRISPR-Cas9 gene-editing technology, hasVariant, SaCas9]
Generated description
SaCas9 is a compact Cas9 nuclease derived from Staphylococcus aureus that enables CRISPR-based genome editing, particularly useful where smaller delivery vectors such as AAV are required.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: SaCas9 Target entity description: SaCas9 is a compact Cas9 nuclease derived from Staphylococcus aureus that enables CRISPR-based genome editing, particularly useful where smaller delivery vectors such as AAV are required.
-
A.
Cpf1 (Cas12a)
Cpf1 (Cas12a) is a CRISPR-associated endonuclease used for genome editing that recognizes different DNA target sequences and creates staggered cuts, offering distinct advantages and applications compared to Cas9.
-
B.
CASP13
CASP13 is the 13th Critical Assessment of protein Structure Prediction experiment, an international community-wide competition that benchmarks computational methods for predicting 3D protein structures.
-
C.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
-
D.
CASP14
CASP14 is the fourteenth edition of the Critical Assessment of protein Structure Prediction experiment, a community-wide benchmark for evaluating computational methods in protein structure modeling.
-
E.
CESAER
CESAER is a European association of leading universities of science and technology that collaborates to advance engineering education, research, and innovation.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d85a113ee881908e297a1d38dd79fa |
completed | April 10, 2026, 2:01 a.m. |
| NER | Named-entity recognition | batch_69e03dd050108190a584543cb93943a4 |
completed | April 16, 2026, 1:39 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ff01e70a308190a7d6b91178c39bd3 |
completed | May 9, 2026, 9:44 a.m. |
| NEDg | Description generation | batch_69ff02745d1c819099f6261eced78dd0 |
completed | May 9, 2026, 9:46 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ff031d58048190852dae8a18981d35 |
completed | May 9, 2026, 9:49 a.m. |
Created at: April 10, 2026, 3:16 a.m.